Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Februar 2014 07:30 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces a New Breakthrough for Diagnosis and Prediction of Kidney Cancer Outcomes Using Its Proprietary Genomic Test

Significant Advancement in the Classification and Prediction of Kidney Cancer Outcomes Validated in Collaborative 191 Patient Clinical Study with Cleveland Clinic Using CGI's Genomic...
20. Februar 2014 07:50 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. New Clinical Trial Backlog Exceeds $13 Million

RUTHERFORD, N.J., Feb. 20, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, initiated two additional multi-year...
18. Februar 2014 07:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics is Pleased to Announce the Appointment of Dr. Paul Rothman, Dean of the Medical Faculty and CEO of Johns Hopkins Medicine, to Its Board of Directors

RUTHERFORD, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today the addition of Paul Rothman, MD, Dean of the Medical...
10. Februar 2014 16:01 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics to Provide Corporate Update at 16th Annual BIO CEO & Investor Conference in New York

RUTHERFORD, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that Panna Sharma, President and Chief Executive Officer...
10. Februar 2014 07:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. and Roche Announce Expanded, Exclusive International Agreement to Provide Molecular Diagnostic Cancer Testing

CGI Will Be the Exclusive Provider of Molecular Diagnostic Cancer Testing for Roche Servicios in Central America and the Caribbean CGI Will Develop A Center of Excellence for Lung Cancer...
29. Januar 2014 07:20 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. Launches Webinar Series to Drive Awareness and Adoption of Its Proprietary DNA-Based Cervical Cancer Diagnostic Test

RUTHERFORD, N.J., Jan. 29, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, is launching a webinar series to inform...
28. Januar 2014 07:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. Increases Access to Its Full-Suite of Cancer Diagnostic Services Through Agreement With Three Rivers Provider Network

RUTHERFORD, N.J., Jan. 28, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced the Company executed an...
23. Januar 2014 07:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. CEO Panna Sharma to Present at the 4th Annual Life Science Chief Executive Officer Forum

RUTHERFORD, N.J., Jan. 23, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced its CEO Panna Sharma will...
21. Januar 2014 07:30 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. Awarded $1.8 Million in Non-Dilutive Financing From New Jersey's Technology Business Tax Certificate Transfer Program

RUTHERFORD, N.J., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, announced that it has been awarded...
08. Januar 2014 07:00 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present at Two Investor Conferences in January

RUTHERFORD, N.J., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced its CEO Panna Sharma will...

Vorherige Seite